The rising prevalence of immunocompromised patients and the high incidence of candidiasis have made Candida auris a significant issue in critical care medicine, as it is the most common cause of fungal infections. The Infection Prevention and Control working group of the International Society of Antimicrobial Chemotherapy convened a meeting of experts in infection prevention and mycology to assess guidelines for healthcare workers regarding infection prevention and control measures for C. auris in inpatient healthcare facilities. The predominant interventions encompassed screening, implementation of standard precautions, thorough cleaning and disinfection, transportation of patients within the hospital, management of outbreaks, decolonization procedures, and provision of medication.